<DOC>
	<DOCNO>NCT01743222</DOCNO>
	<brief_summary>The objective determine safety , tolerability feasibility inguinal intralymphatic administration expand allogeneic adipose-derived stem cell ( eASCs )</brief_summary>
	<brief_title>Intralymphatic eASC Administration Healthy Volunteers</brief_title>
	<detailed_description>Phase I , unicentric , single blind , clinical trial healthy volunteer determine feasibility new administration technique .</detailed_description>
	<criteria>Age 18 55 include Inform Consent Form sign Body Mass Index ( BMI ) 19 29 kg/m2 Presence , least , one lymph node 1cm large diameter inguinal location . It accessible administration localization use ultrasound scan . Pregnant ( positive urine pregnancy test ) breastfeed woman . Subjects history organic psychic pathology record , physical exploration complementary test . Any relevant current pathology , include cancer , liver pathology , gastrointestinal dysfunction , renal alteration , respiratory pathology active acute infectious problem . Chronic disorder previous recurrent like hypertension , infection , cardiovascular , respiratory , endocrine , neurologic , hematologic , renal liver disorder . Subjects treat four week first administration drug , medicinal plant Consumer Health Care continue routine . It consider exclusion criterion sporadic medication . The physician study interaction eASC medication . History hypersensibility drug . Volunteers participant clinical trial within 4 month prior start study . Blood derivative transfusion 6 month trial . Known history abuse alcohol addictive substance ( amount alcohol allow maximum trial 0.5 liter wine two beer amount grams equivalent alcoholic drink ) . Illegal drug consumption month enrollment study positive result drug test . Positive serology B hepatitis virus ( HbsAg ) , C hepatitis virus HIV ( Human Inmunodeficiency Virus ) . Subjects whose freedom depend legal administrative requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>